Details for New Drug Application (NDA): 020723
✉ Email this page to a colleague
The generic ingredient in ALDARA is imiquimod. There are fourteen drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the imiquimod profile page.
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CREAM;TOPICAL | Strength | 5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Feb 27, 1997 | TE: | RLD: | Yes | |||||
Expired US Patents for NDA 020723
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Bausch | ALDARA | imiquimod | CREAM;TOPICAL | 020723-001 | Feb 27, 1997 | ⤷ Get Started Free | ⤷ Get Started Free |
| Bausch | ALDARA | imiquimod | CREAM;TOPICAL | 020723-001 | Feb 27, 1997 | ⤷ Get Started Free | ⤷ Get Started Free |
| Bausch | ALDARA | imiquimod | CREAM;TOPICAL | 020723-001 | Feb 27, 1997 | ⤷ Get Started Free | ⤷ Get Started Free |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription
